Navigation Links
Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website
Date:7/8/2009

SAN MARINO, Calif., July 8 /PRNewswire-FirstCall/ -- Biotechnology company Viral Genetics (Pink Sheets: VRAL) has begun making corporate and financial disclosures through the OTCIQ.com portal, that provides information free of charge via the www.pinksheets.com website. The website is an online point of access for information concerning issuers listed on the "Pink Sheets" over-the-counter market. Investors can access and download all Viral Genetics financial reports, current reports, and other announcements that the company makes through OTCIQ at the pinksheets.com website. The company will also continue providing updates through regular press releases where appropriate.

On March 25, 2009, the company filed a Form 15 with the Securities and Exchange Commission terminating its reporting obligations under Section 12(g) of the Securities Exchange Act of 1934. As a result, the company was no longer eligible or required to make ongoing disclosures and reports under the SEC's online EDGAR system including annual and quarterly reports on Form 10-QSB or Form 10-KSB, as well as Current Reports on Form 8-K. The company intends to address this gap in disclosure by making disclosures under the OTCIQ service until such time as the company recommences making filings under EDGAR which would require re-registration with the SEC.

Re-registration would require the filing of audited financial statements, amongst other requirements. Doing so will be dependent on Viral Genetics securing sufficient resources to complete the necessary audits, legal documentation, and other items. While the company intends to do so, there is no guarantee that it will occur.

Disclosure on the OTCIQ system is made pursuant to the "Guidelines for Providing Adequate Current Information" available at '/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
2. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
3. Companys Partner Completes Trial Production of a New Antiviral Medicine
4. Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
5. SAFC Pharma to Increase Viral Product Manufacturing Capacity
6. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
7. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
8. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
9. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
10. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
11. Researchers decode viral process that prepares cells for HIV infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Pipette.com has added the ... their comprehensive portfolio of Eppendorf products. , The Eppendorf ... a Centrifuge 5424/5424 R and receive the following:, ... Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... Denville, NJ (PRWEB) January 22, 2015 ... shearing technologies such as the Bioruptor® and complete ... semi-automation system for chromatin immunoprecipitation, alleviating the need ... reagents and controls needed for ChIP of histones ...
(Date:1/22/2015)... N.J. , Jan. 22, 2015  Derma Sciences, ... regeneration company focused on advanced wound care, announces ... placental tissues, have been added to the Premier, ... increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® ...
(Date:12/24/2014)... BioLife Solutions , Inc. (NASDAQ: BLFS ), a ... hypothermic storage and cryopreservation freeze media and ... ("BioLife" or the "Company"), today announced that it will hold ... (the "Annual Meeting"). Because the expected date for ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... 7 Odyssey Thera, Inc. announced,that it has ... decision to progress a discovery stage drug candidate ... by,Odyssey Thera as part of the ongoing collaboration ... the progress of the collaboration with,Pfizer," said John ...
... Aug. 7 AutoImmune Inc. (OTC,Pink Sheets: AIMM) today reported ... diluted, for the three months ended June 30, 2008, compared ... basic and diluted, for the,three months ended June 30, 2007. ... was $193,000, or $0.01 per share basic and diluted, compared,with ...
... (Nasdaq: KERX ) will hold a conference call ... discuss the second quarter 2008 financial results.,Michael S. Weiss, ... the call. Keryx will announce its financial results for ... to the call., In order to participate in ...
Cached Biology Technology:AutoImmune Inc. Reports 2008 Second Quarter Financial Results 2AutoImmune Inc. Reports 2008 Second Quarter Financial Results 3Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT 2
(Date:1/22/2015)... 2015  Today, FreeWavz ( www.FreeWavz.com ), the developer ... on Fundable, https://www.fundable.com/freewavz . FreeWavz will be ... to meet customer demand. Logo - ... Invented by Dr. ...
(Date:1/22/2015)... POINT ROBERTS, Washington , January 20, 2015 ... technology and tech stocks, releases video from the CES 2015 ... security consultant Apollo Robbins . Apollo shows ... Wocket™ biometric smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
(Date:1/22/2015)... has launched its new NXG series of time clocks with ... higher standard for collecting attendance and labor data and complements ... touch screen interface and seamless connection to cloud-based iSolved, the ... for the small to mid-size employer. The G2 ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Infinisource's NXG series sets new time clock standard 2
... This week, research was published showing that silk produced ... Jr., professor of biological sciences at University of Notre ... spider silk. This stronger silk could possibly be used ... findings were published in the Proceedings of the ...
... Sciences Research Council have shown one way in which poor ... risk of developing type 2 diabetes and other age-related diseases ... of identifying people who are at a higher risk of ... The team, from the University of Cambridge and the ...
... for taxonomic studies on the members of the ginger family (Zingiberaceae) ... University of Calicut , have resulted in the discovery of an ... Park on the Western Ghats of Kerala. The ginger ... which are widely used as spices, for medical purposes, or simply ...
Cached Biology News:Hybrid silkworms spin stronger spider silk 2How poor maternal diet can increase risk of diabetes -- new mechanism discovered 2How poor maternal diet can increase risk of diabetes -- new mechanism discovered 3
Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
... Clone/PAD: ZMD.283. Immunogen: Fusion ... Specificity: Specific for ASIP/PAR-3 (atypical PKC ... This antigen is not related to ... Reactivity: Human Dog Xenopus (positive controls: ...
...
Request Info...
Biology Products: